comprehensive -WSS

comprehensive

author：explore 2025-09-30 18:58:54 - browse：972

Cathy McMorris Rodgers — hospitals coverage from STAT — House Energy & Commerce Chair Cathy McMorris Rodgers (R-Wash.) Kevin Dietsch/Getty Images

WASHINGTON — A House subcommittee will next week mark up a package of public health bills, including pandemic-preparedness legislation, according to five lobbyists.

The House Energy & Commerce Committee hasn’t yet announced the markup, and the lobbyists didn’t know the exact date. But time is running out for reauthorizing a law that created several of the federal government’s biodefense and pandemic-preparedness programs.

The Pandemic All-Hazards Preparedness Act was enacted in 2006 to help the government respond to nuclear and biological weapons, naturally occurring threats like avian influenza, and natural disasters. Those programs include the Administration for Strategic Preparedness and Response, which runs the country’s stockpile of medical supplies and coordinates responses to pandemics and other national emergencies, and the Biomedical Advanced Research and Development Authority, which promotes development of medical products that defend against those threats.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Intellia reports positive results for its CRISPR

leisure time

WSS

ASCO: AstraZeneca says CAR

ASCO: AstraZeneca says CAR

NIH documents show early flaws of $1.6 billion long Covid program

HIV drugs protect against transmission, even in unprotected sex

Cord blood banking comes at a high cost to babies

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

knowledge

comprehensive

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

After affirmative action ruling, medical educators look to 'holistic review'

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Apple is now the first public company to be valued at $3 trillion

BMI, flaws aside, is found to be useful estimate of body fat in youth

Affirmative action in medical school literally saved lives

Ultragenyx gene therapy for rare liver ailment succeeds in late

Moonlake's readout produced a cash windfall. Risks remain

Let's speed up science by embracing open access publishing

entertainment

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

At ASCO, AstraZeneca reports strong data for breast cancer drug

Kaiser's Risant Health gobbled up Geisinger. Who is next?

At ASCO, AstraZeneca reports strong data for breast cancer drug

Change Healthcare can notify patients about the breach, HHS says

With trial win, GSK could get blood cancer drug back on market

leisure time

hotspot

focus

hotspot